BRUSSELS, Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR: Quote, Profile, Research) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden’s Perstorp Group.
BRUSSELS, Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR: Quote, Profile, Research) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden’s Perstorp Group.
